Cabaletta Bio Files 8-K for Operations and Financials

Ticker: CABA · Form: 8-K · Filed: Mar 31, 2025 · CIK: 1759138

Sentiment: neutral

Topics: financial-reporting, 8-k

TL;DR

Cabaletta Bio dropped its 8-K. Standard financial reporting, no major news.

AI Summary

Cabaletta Bio, Inc. filed an 8-K on March 31, 2025, reporting on its results of operations and financial condition, as well as presenting financial statements and exhibits. The filing does not contain specific financial figures or operational updates beyond the reporting of these standard sections.

Why It Matters

This filing indicates Cabaletta Bio is adhering to its reporting obligations, providing investors with a snapshot of its financial status and operational results as of March 31, 2025.

Risk Assessment

Risk Level: low — This is a routine filing for financial reporting and does not contain new material information that would inherently increase risk.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing by Cabaletta Bio, Inc.?

The primary purpose of this 8-K filing is to report on Cabaletta Bio, Inc.'s results of operations and financial condition, and to present financial statements and exhibits as of March 31, 2025.

On what date was this 8-K report filed or effective?

The report was filed as of March 31, 2025, and the date of the earliest event reported is also March 31, 2025.

What is Cabaletta Bio, Inc.'s principal executive office address?

Cabaletta Bio, Inc.'s principal executive office is located at 2929 Arch Street, Suite 600, Philadelphia, Pennsylvania, 19104.

What is the telephone number for Cabaletta Bio, Inc.?

The registrant's telephone number, including area code, is (267) 759-3100.

What is Cabaletta Bio, Inc.'s Standard Industrial Classification (SIC) code?

Cabaletta Bio, Inc.'s Standard Industrial Classification (SIC) code is 2836, which corresponds to BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES).

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on March 31, 2025 regarding Cabaletta Bio, Inc. (CABA).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing